A Randomized, Double-blind, Ascending Multiple-dose study to Evaluate the Pharmacokinetics of setrobuvir in Healthy Volunteers.
Latest Information Update: 13 Oct 2015
Price :
$35 *
At a glance
- Drugs Setrobuvir (Primary)
- Indications Hepatitis C
- Focus Pharmacokinetics
- 13 Oct 2015 New trial record